Omron Corp. (OTCMKTS:OMRNY) Short Interest Down 20.9% in February

Omron Corp. (OTCMKTS:OMRNY) was the recipient of a significant drop in short interest during the month of February. As of February 13th, there was short interest totaling 12,759 shares, a drop of 20.9% from the January 29th total of 16,138 shares. Based on an average trading volume of 161,213 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are short sold. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 161,213 shares, the days-to-cover ratio is presently 0.1 days.

Omron Price Performance

OTCMKTS OMRNY opened at $35.32 on Monday. Omron has a 1 year low of $23.23 and a 1 year high of $35.90. The business’s fifty day moving average is $27.71 and its two-hundred day moving average is $27.07. The stock has a market capitalization of $7.28 billion, a P/E ratio of 44.71, a P/E/G ratio of 0.55 and a beta of 0.91. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.37 and a current ratio of 2.11.

Omron (OTCMKTS:OMRNY) last issued its earnings results on Thursday, February 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.19). Omron had a return on equity of 2.46% and a net margin of 2.80%.The company had revenue of $1.41 billion during the quarter, compared to analyst estimates of $1.38 billion. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. On average, research analysts forecast that Omron will post 0.42 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Omron from a “strong sell” rating to a “hold” rating in a research note on Monday, January 19th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Institutional Trading of Omron

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC boosted its position in shares of Omron Corp. (OTCMKTS:OMRNY) by 50.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent reporting period. 1.09% of the stock is currently owned by hedge funds and other institutional investors.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.